Date: Thursday, June 6, 2024 Presentation time: 2:00pm ET Location: Convene – 810 7th Ave., NYC – 23rd Floor Registration: MicroCap Rodeo - Spring into Summer | Registration Webcast link: https://www.webcaster4.com/Webcast/Page/3045/50680 Management will be available for one-on-one meetings at each conference and a live webcast of each presentation will be accessible on the News & Events section of the Company's Investor Relations website at https://lifevantage.gcs-web.com/. Shortly following each presentat ...

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2024 Salt Lake City, UT, May 2, 2024, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2024. Third Quarter Fiscal 2024 Summary*: * All comparisons are on a year over year basis and compare the third quarter of fiscal 2024 to the third quarter of fisc ...

Financial Performance - Total revenue for the three months ended March 31, 2024, was $48,245,000, a decrease of 9.3% compared to $53,741,000 for the same period in 2023[16] - Gross profit for the three months ended March 31, 2024, was $38,073,000, down from $43,123,000 in the same period last year, reflecting a gross margin decrease[16] - Net income for the three months ended March 31, 2024, was $1,659,000, an increase of 62.4% compared to $1,022,000 for the same period in 2023[16] - Commissions and incentives for the three months ended March 31, 2024, were $19,714,000, down from $23,816,000 in the same period last year, a decrease of 17.6%[16] - Selling, general and administrative expenses for the three months ended March 31, 2024, were $16,425,000, slightly down from $17,708,000 in the same period last year[16] - The company reported a basic net income per share of $0.13 for the three months ended March 31, 2024, compared to $0.08 for the same period in 2023[16] - Net income for the nine months ended March 31, 2024, was $1,632,000, compared to $574,000 for the same period in 2023, representing an increase of 184%[23] - Cash provided by operating activities for the nine months ended March 31, 2024, was $9,615,000, significantly higher than $3,065,000 for the same period in 2023[23] - The Company recognized income tax expense of $7,000 for the nine months ended March 31, 2024, compared to $0.9 million for the same period in 2023[54] - Net foreign currency losses for the three months ended March 31, 2024, were $0.1 million, compared to gains of $36,000 for the same period in 2023[33] Assets and Liabilities - Total current assets decreased to $37,797,000 as of March 31, 2024, from $44,284,000 as of June 30, 2023, representing a decline of 14.6%[15] - Total liabilities increased to $34,538,000 as of March 31, 2024, compared to $31,474,000 as of June 30, 2023, indicating a rise of 9.8%[15] - The total stockholders' equity decreased to $26,769,000 as of March 31, 2024, from $34,649,000 as of June 30, 2023, a decline of 22.8%[15] - Total assets as of March 31, 2024, were $136,198,000, reflecting a growth from $133,424,000 as of March 31, 2023[20] - The Company had $13.1 million in cash accounts at one financial institution as of March 31, 2024, down from $17.0 million as of June 30, 2023[35] Stock and Dividends - The Company repurchased $4,599,000 worth of its stock during the nine months ended March 31, 2024[23] - Cash dividends paid during the nine months ended March 31, 2024, totaled $6,437,000, compared to $1,141,000 for the same period in 2023[23] - In August 2023, the Board of Directors declared a quarterly cash dividend of $0.035 per share and a one-time cash dividend of $0.40 per share, with total cash dividends for the three and nine months ended March 31, 2024 amounting to $0.4 million and $6.4 million, respectively[77] - The Company purchased 0.3 million shares of common stock for $1.9 million under the repurchase program during the three months ended March 31, 2024[72] - The Company has $22.3 million remaining under its share repurchase program as of March 31, 2024[72] Inventory and Expenses - As of March 31, 2024, total inventory was $15.162 million, a decrease of 5.7% from $16.073 million as of June 30, 2023[37] - Finished goods accounted for 74.4% of total inventory as of March 31, 2024, compared to 75.6% as of June 30, 2023[37] - Research and development expenses for the nine months ended March 31, 2024, were $0.5 million, an increase from $0.4 million for the same period in 2023[45] - Operating lease expense for the three months ended March 31, 2024, was $0.5 million, down from $0.6 million in 2023[61] - Stock-based compensation for the nine months ended March 31, 2024, was $2,524,000, up from $2,242,000 for the same period in 2023[23] Future Outlook - The company anticipates ongoing challenges in managing existing markets and expanding into new international markets, which may impact future performance[10] - The Company assesses potential contingent liabilities and has determined there are no probable loss contingencies requiring accrual as of March 31, 2024[86] Market Operations - The company operates in multiple international markets, including the United States, Mexico, Japan, and several European countries, and has ceased its e-commerce operations in China as of March 15, 2023[27] Loan Agreements - The Company entered into a new Loan Agreement on April 12, 2024, providing for a revolving line of credit of up to $5.0 million[69] - The Loan Agreement includes covenants that restrict the Company's ability to incur additional indebtedness and requires maintenance of specified financial ratios[92] - As of the date of the report, the Company has not borrowed under the 2024 Credit Facility[94]

LifeVantage Corporation (NASDAQ:LFVN) Q2 2024 Results Conference Call January 30, 2024 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President, CEO Carl Aure - CFO Conference Call Participants Doug Lane - Water Tower Research Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to today's Conference Call to Discuss LifeVantage's Second Quarter of Fiscal 2024 Results. [Operator Instructions] Hosting today's conference will be Reed Anderson with ICR. As a reminder, to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________ Form 10-Q ________________________________________________________________________________ ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commissi ...

LifeVantage Corporation (NASDAQ:LFVN) Q1 2024 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President & Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Doug Lane - Water Tower Research Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to today's conference call to discuss LifeVantage's First Quarter of Fiscal 2024 Results. [Operator Instructions] Hosting today's conference will be ...

Financial Performance - For the three months ended September 30, 2023, net revenue was $51,364,000, a decrease of 0.8% compared to $51,774,000 for the same period in 2022[17] - Gross profit for the quarter was $41,184,000, down from $41,832,000 year-over-year, reflecting a gross margin of approximately 80.1%[17] - Operating income decreased to $749,000 from $1,290,000 in the prior year, indicating a decline of 42%[17] - Net income for the quarter was $629,000, slightly up from $610,000 in the same quarter last year, resulting in a net income per share of $0.05[17] - The company reported a comprehensive income of $335,000 for the quarter, compared to $100,000 in the same period last year[17] - Net income for the three months ended September 30, 2023, was $629,000, an increase from $610,000 in the same period of 2022, representing a growth of approximately 3.1%[24] Assets and Liabilities - Total current assets decreased to $41,901,000 as of September 30, 2023, down from $44,284,000 at the end of the previous quarter[15] - Total liabilities increased to $37,310,000 from $31,474,000, primarily due to an increase in accounts payable and current liabilities[15] - Cash and cash equivalents decreased to $18,405,000 from $21,605,000, indicating a cash reduction of approximately 14%[15] - The accumulated deficit increased to $104,005,000 as of September 30, 2023, from $98,305,000 at the end of the previous quarter[15] - Total inventory as of September 30, 2023, was $15,706,000, a decrease from $16,073,000 as of June 30, 2023, indicating a reduction of approximately 2.3%[38] Cash Flow and Dividends - Cash flows from operating activities provided $4,765,000 in Q3 2023, a significant improvement compared to a cash outflow of $1,345,000 in Q3 2022[24] - The company paid $5,534,000 in cash dividends during the three months ended September 30, 2023, compared to $377,000 in the same period of 2022[24] - Cash and cash equivalents at the end of the period were $18,405,000, compared to $17,619,000 at the end of the same period in 2022, showing an increase of approximately 4.5%[24] - The board of directors declared a quarterly cash dividend of $0.035 per share and a one-time cash dividend of $0.40 per share, totaling $5.5 million for the three months ended September 30, 2023[79] - Cash dividends for the same period in 2022 totaled $0.4 million, or $0.03 per share, indicating a significant increase in dividend payouts year-over-year[80] Research and Development - Research and development expenses for the three months ended September 30, 2023, were $200,000, up from $100,000 in the same period of 2022, reflecting a 100% increase[46] Stock and Shareholder Information - The Company issued 0.3 million shares of common stock under equity award plans during the three months ended September 30, 2023, compared to 48,000 shares in the same period of 2022[73] - The Company has a remaining balance of $26.1 million under its share repurchase program as of September 30, 2023, having purchased 0.1 million shares at an aggregate price of $0.8 million during the three months ended September 30, 2023[74] - Stock-based compensation for the three months ended September 30, 2023, was $1.0 million, compared to $0.6 million for the same period in 2022, reflecting a 66.67% increase[88] - Approximately 39,000 shares of common stock were issued under the Employee Stock Purchase Plan (ESPP) during the three months ended September 30, 2023, compared to 36,000 shares in the same period of 2022[87] - The company has reserved 0.4 million shares of its common stock for issuance under the ESPP, with 0.1 million shares available as of September 30, 2023[84] Market and Operational Challenges - The company anticipates ongoing challenges in managing independent consultants and expanding into new international markets, which may impact future performance[10] - The company closed its e-commerce business in China on March 15, 2023, impacting its market presence in that region[28] Other Financial Information - The effective interest rate on the Company's 2016 Credit Facility was 8.55% as of September 30, 2023, with no balance outstanding on the facility at that date[72] - The Company recognized income tax expense of $0.2 million for both the three months ended September 30, 2023, and 2022, reflecting its current estimated effective tax rate[54] - The Company has no remaining lease liability for the abandoned showrooms in Hong Kong and Singapore, which were terminated in February 2023[49] - The weighted average remaining lease term for operating leases was 7.78 years as of September 30, 2023, down from 8.27 years as of June 30, 2023[61] - The Rights Plan is set to expire on August 24, 2024, unless terminated earlier, and aims to protect the interests of the company and its stockholders[77] - As of September 30, 2023, no preferred stock has been issued, and no rights or preferences have been assigned to preferred stock by the board of directors[78] - The company assessed potential contingent liabilities and found no probable loss contingencies requiring accrual or disclosures as of September 30, 2023[89] - There were no substantial changes to market risks during the quarter ended September 30, 2023, compared to the previous disclosures[138]

LifeVantage Corporation (NASDAQ:LFVN) Q4 2023 Earnings Conference Call August 28, 2023 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President and CEO Carl Aure - CFO Conference Call Participants Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to today's conference call to discuss LifeVantage's Fourth Quarter and Full Fiscal Year 2023 Results. [Operator Instructions] I would like to inform you that LifeVantage intends to file a proxy statement and related proxy ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________________________________________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended June 30, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from __________ to __________ Commission file number: 001-35647 ________________________________________ ...

LifeVantage Corporation (NASDAQ:LFVN) Q3 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President and Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to today's conference call to discuss LifeVantage's Third Quarter Fiscal 2023 Results. [Operator Instructions] Hosting today's conference will be Reed Anderson with ICR. As a reminder, ...